The estimated Net Worth of Bryant David Lim is at least $759 Tausend dollars as of 24 May 2023. Mr. Lim owns over 2,400 units of Idera Pharmaceuticals stock worth over $1,032 and over the last 6 years he sold IDRA stock worth over $26,162. In addition, he makes $731,795 as Senior Vice President, General Counsel und Corporate Secretary at Idera Pharmaceuticals.
Sign up
Mr. Lim IDRA stock SEC Form 4 insiders trading
Bryant has made over 6 trades of the Idera Pharmaceuticals stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 2,400 units of IDRA stock worth $12,936 on 24 May 2023.
The largest trade he's ever made was selling 7,630 units of Idera Pharmaceuticals stock on 25 March 2021 worth over $10,377. On average, Bryant trades about 990 units every 85 days since 2018. As of 24 May 2023 he still owns at least 2,400 units of Idera Pharmaceuticals stock.
You can see the complete history of Mr. Lim stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Bryant Lim biography
Bryant David Lim J.D. serves as Senior Vice President, General Counsel, Corporate Secretary of the Company. Mr. Lim most recently served as Vice President, Assistant General Counsel of Incyte Corporation. Prior to Incyte, Mr. Lim held roles of increasing responsibility at ViroPharma Incorporated, Merck & Co., Inc. and Morgan, Lewis & Bockius, LLP. Mr. Lim began his legal career as a law clerk for a federal judge. Mr. Lim received his J.D. from Villanova University School of Law, where he serves on its adjunct faculty. Mr. Lim received his Bachelor of Arts from University of Rochester.
What is the salary of Bryant Lim?
As the Senior Vice President, General Counsel und Corporate Secretary of Idera Pharmaceuticals, the total compensation of Bryant Lim at Idera Pharmaceuticals is $731,795. There are 2 executives at Idera Pharmaceuticals getting paid more, with Vincent Milano having the highest compensation of $1,337,220.
How old is Bryant Lim?
Bryant Lim is 49, he's been the Senior Vice President, General Counsel und Corporate Secretary of Idera Pharmaceuticals since 2018. There are 15 older and 1 younger executives at Idera Pharmaceuticals. The oldest executive at Idera Pharmaceuticals, Inc. is Dr. Sudhir Agrawal D.Phil., DPHIL, F.R.S.C., 67, who is the Scientific Advisor.
What's Bryant Lim's mailing address?
Bryant's mailing address filed with the SEC is 505 Eagleview Blvd, Exton, PA 19341, USA.
Insiders trading at Idera Pharmaceuticals
Over the last 17 years, insiders at Idera Pharmaceuticals have traded over $20,746,904 worth of Idera Pharmaceuticals stock and bought 38,459,430 units worth $53,771,070 . The most active insiders traders include Bros. Advisors Lp14159, L.P..., Bros. Advisors Lp Baker Bro... und Invest Corp Pillar Pharmace.... On average, Idera Pharmaceuticals executives and independent directors trade stock every 43 days with the average trade being worth of $309,429. The most recent stock trade was executed by John J. Kirby on 17 December 2021, trading 10,000 units of IDRA stock currently worth $6,200.
What does Idera Pharmaceuticals do?
Harnessing the approach of the earliest researchers in immunotherapy and the company's vast experience in developing proprietary immunology platforms, Idera's development program is focused on priming the immune system to play a more powerful role in fighting cancer, ultimately increasing the number of people who can benefit from immunotherapy. Idera also continues to focus on the acquisition, development, and ultimate commercialization of drug candidates for both oncology and rare disease indications characterized by small, well-defined patient populations with serious unmet needs.
What does Idera Pharmaceuticals's logo look like?
Complete history of Mr. Lim stock trades at Idera Pharmaceuticals und Prelude Therapeutics Inc
Idera Pharmaceuticals executives and stock owners
Idera Pharmaceuticals executives and other stock owners filed with the SEC include:
-
Vincent Milano,
President, Chief Executive Officer, Director -
Robert Fletcher,
Senior Vice President - Business Development and Strategic Planning -
Bryant Lim,
Senior Vice President, General Counsel, Corporate Secretary -
John Kirby,
Chief Financial Officer, Senior Vice President -
Bryant David Lim,
Sr. VP, Gen. Counsel & Corp. Sec. -
John J. Kirby,
Sr. VP & CFO -
Vincent J. Milano,
Pres, CEO & Director -
james Geraghty,
Independent Chairman of the Board -
Carol Schafer,
Independent Director -
Maxine Gowen,
Independent Director -
Mark Goldberg,
Independent Director -
Michael Dougherty,
Independent Director -
Cristina Csimma,
Independent Director -
Elizabeth Tarka,
Senior Vice President, Chief Medical Officer -
Louis J. Arcudi III, M.B.A., MBA,
Adviser -
Dr. Sudhir Agrawal D.Phil., DPHIL, F.R.S.C.,
Scientific Advisor -
Dr. Sudhir Agrawal,
Scientific Advisor -
Dr. Joanna C. Horobin Ch.B, M.B.,
Advisor -
Dr. Shah Rahimian M.D., Ph.D.,
Medical Director & Global Clinical Lead for Oncology -
Elizabeth Eberhardt,
Sr. VP of Product Leadership -
Jill Conwell,
Sr. VP of Investor Relations & Corp. Communications -
Daniel B. Soland,
Sr. VP & COO -
Bros. Advisors Lp667, L.P.B...,
-
William S Reardon,
Director -
Invest Corp Pillar Pharmace...,
-
Iii Louis J Arcudi,
Chief Financial Officer -
Julianbaker Bros. Advisors ...,
-
Invest Corp Pillar Pharmace...,
-
Bros. Advisors Lp Baker Bro...,
-
Invest Corp Pillar Pharmace...,
-
Mark J Casey,
Senior VP and General Counsel -
Julian Baker Bros. Advisors...,
-
Youssef El Zein,
Director -
Bros. Advisors Lp Baker Bro...,
-
Alice Bexon,
V.P. Clinical Development -
Alison Taunton Rigby,
Director -
Sudhir Agrawal,
CEO & CSO -
Invest Corp Pillar Pharmace...,
-
Bros. Advisors Lp14159, L.P...,
-
Invest Corp Pillar Pharmace...,
-
Invest Corp Pillar Pharmace...,
-
Jonathan Michael Yingling,
Chief Scientific Officer -
Invest Corp Pillar Pharmace...,
-
Invest Corp Pillar Pharmace...,
-
Howard H Pien,
Director -
Invest Corp Pillar,
10% owner -
Paul C Zamecnik,
-
Joanna Horobin,
SVP and Chief Medical Officer -
Eve Elizabeth Slater,
Director -
Malcolm Mac Coss,
Director -
Timothy M Sullivan,
VP Development Programs -
Umari Abdul Wahab,
Director -
Louis Md Brenner,
Chief Medical Officer -
Robert D. Arbeit,
VP Clinical Development -
Robert W Karr,
Director -
Pharmaceuticals I Lpzein Yo...,
-
John Peter Iii Wolf,
General Counsel -
Invest Corp Pillar Pharmace...,
-
C Keith Hartley,
Director -
Investment Group Lp Senator,
10% owner -
Invest Corp Zein Youssef El...,
-
Hans Mueller,
Director -
James B Wyngaarden,
Director -
Invest Corp Pillar Pharmace...,
-
Invest Corp Pillar Partners...,
-
Invest Corp Pillar Partners...,
-
Daniel B Soland,
CHIEF OPERATING OFFICER -
John Clayton Taylor,
Chief Executive Officer -
Ronald J Wooten,
Director -
Carl N Kraus,
Chief Medical Officer -
Daniel Salain,
Chief Operating Officer -
Co Investment Fund Xv, L.P....,